Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wubai Lishi (五白利湿颗粒) is a traditional Chinese medicine formulation, typically presented as granules. The name suggests it is used to "benefit dampness" (利湿), which in Traditional Chinese Medicine (TCM) refers to promoting the removal of excess moisture or dampness from the body—a concept associated with symptoms such as edema, heaviness, and digestive issues. The "Wubai" ("five whites") likely refers to a combination of five white-colored herbal ingredients commonly used in TCM for their purported effects on fluid metabolism and spleen function. However, there is no evidence that this product corresponds to an internationally recognized pharmaceutical drug or that its mechanism of action has been characterized by modern pharmacology. Its use and composition are based on TCM theory rather than Western biomedical mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wubai Lishi.